Masimo Corporation
Masimo Corporation (MASI) Revenue
Annual & quarterly revenue history · segment & region breakdown
MASI · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMasimo Corporation trailing twelve-month (TTM) revenue is $1.56B, a decrease of 27.10% year-over-year from $1.53B in FY2026.
Revenue trend
2026 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-01-03 | $1.53B | -$0.57B | -27.10% |
| 2024-12-28 | $2.09B | +$0.05B | +2.26% |
| 2023-12-31 | $2.05B | +$0.01B | +0.60% |
| 2022-12-31 | $2.04B | +$0.80B | +64.28% |
| 2021-12-31 | $1.24B | +$0.10B | +8.35% |
| 2020-12-31 | $1.14B | +$0.21B | +21.95% |
| 2019-12-31 | $0.94B | +$0.08B | +9.27% |
| 2018-12-31 | $0.86B | +$0.07B | +8.61% |
| 2017-12-31 | $0.79B | +$0.08B | +10.85% |
| 2016-12-31 | $0.71B | +$0.08B | +13.14% |
Compare revenue vs peers
Medical - DevicesCompare MASI revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Masimo Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Masimo Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Masimo Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MASI revenue · 4 questionsMASI's trailing twelve-month (TTM) revenue is $1.56B. That is a decrease of 27.10% year-over-year from $1.53B in FY2026.
▸ Source: FMP · Masimo Corporation SEC filings · GAAP · Masimo Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026